Abbott Laboratories today announced that its over‑the‑counter continuous glucose monitor, Lingo, is now available for Android devices, expanding access to real‑time glucose data for millions of users.
The Lingo system, already available on iOS, offers a non‑invasive way for adults not on insulin to track glucose levels, helping them make informed lifestyle choices. The Android launch broadens Abbott’s reach in the growing consumer diabetes market and supports the company’s strategy of delivering user‑friendly, data‑driven health solutions.
The move is part of Abbott’s broader focus on expanding its diabetes care portfolio, which has seen significant growth in recent quarters. By adding Android support, Abbott positions Lingo to capture a larger share of the consumer CGM market and reinforce its competitive edge in the digital health space.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.